1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. LUCID DIAGNOSTICS INC

Lucid Diagnostics Inc

XNAS: LUCD

Download real time

1.57 0.07 (4.67%)

Near 52W High of $1.63

1.4M XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
18S
7W
1O
2T
131.3

Market Cap

Below industry Median
-2.9

PE TTM

Negative PE TTM
-0.1

PEG TTM

PEG TTM is negative
-2.2

Price to Book

Negative Price to Book
0.4

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Lucid Diagnostics Inc is on 26 Mar 2025 for the purpose of Lucid Diagnostics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Lucid Diagnostics Inc

The latest disclosure was made by Michael Adam Gordon in Lucid Diagnostics Inc where a trade of 300,000 Common stock done was reported to US exchanges on Feb. 20, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael Adam Gordon General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 300,000 700,000 - 0 Common stock
Dennis M. McGrath Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 300,000 1,343,569 - 0 Common stock
Jacque J. Sokolov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 112,800 197,460 - 0 Common Stock
Stanley N. Lapidus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 112,800 214,392 - 0 Common Stock
Ronald M. Sparks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 112,800 197,460 - 0 Common stock
Lishan Aklog Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 300,000 1,466,627 - 0 Common Stock
James L. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 112,800 282,120 - 0 Common Stock
Dennis Matheis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 112,800 162,725 - 0 Common Stock
Debra J. White Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 112,800 112,800 - 0 Common Stock
Dennis Matheis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2024 241,500 241,500 - - Employee stock option (right to buy)
Michael Adam Gordon General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2024 400,000 400,000 - 0 Common stock
Lishan Aklog Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2024 400,000 1,166,627 - 0 Common stock
Dennis M. McGrath Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2024 400,000 1,043,569 - 0 Common stock
L. James Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 150,000 150,000 - - Employee stock option (right to buy)
Debra White Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 150,000 150,000 - - Employee stock option (right to buy)
Ronald Sparks M. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 150,000 150,000 - - Employee stock option (right to buy)
Stanley Lapidus N. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 150,000 150,000 - - Employee stock option (right to buy)
Sokolov J. Jacque Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 150,000 150,000 - - Employee stock option (right to buy)
Debra White Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 175,000 175,000 - - Employee stock option (right to buy)
Stanley N. Lapidus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 175,000 175,000 - - Employee stock option (right to buy)
Ronald M. Sparks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 175,000 175,000 - - Employee stock option (right to buy)
James L. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 175,000 175,000 - - Employee stock option (right to buy)
Jacque J. Sokolov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 175,000 175,000 - - Employee stock option (right to buy)
Stanley N. Lapidus Director Sale of securities on an exchange or to another person at price $ 1.70 per share. 20 Sep 2022 16,864 135,456 - 1.7 28,669 Common stock
Stanley N. Lapidus Director Sale of securities on an exchange or to another person at price $ 1.71 per share. 20 Sep 2022 17,000 152,320 - 1.7 29,014 Common stock
Debra White Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 80,000 80,000 - - Employee stock option (right to buy)
Michael Adam Gordon General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 200,000 200,000 - - Employee stock option (right to buy)
Lishan Aklog Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 75,000 75,000 - - Employee stock option (right to buy)
Stanley N. Lapidus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 59,000 59,000 - - Employee stock option (right to buy)
Ronald M. Sparks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 59,000 59,000 - - Employee stock option (right to buy)
Dennis M. McGrath Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 50,000 50,000 - - Employee stock option (right to buy)
Jacque J. Sokolov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 59,000 59,000 - - Employee stock option (right to buy)
James L. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 59,000 59,000 - - Employee stock option (right to buy)
Aster Angagaw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 59,000 59,000 - - Employee stock option (right to buy)
Dennis M. McGrath Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 60,000 624,400 - 0 Common stock
Lishan Aklog Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2022 60,000 624,400 - 0 Common stock
Ronald M. Sparks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2021 84,660 84,660 - 0 Common stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters